Literature DB >> 26783343

Perception of Reproductive Health in Women with Inflammatory Bowel Disease.

Pierre Ellul1, Stephania Chectuti Zammita2, Konstantinos H Katsanos3, Monica Cesarini4, Mariangela Allocca5, Silvio Danese5, Pantelis Karatzas6, Sara Canora Moreno7, Uri Kopylov8, Gionata Fiorino5, Joana Torres9, Antonio Lopez-Sanroman7, Mandy Caruana2, Louise Zammit2, Gerassimos Mantzaris6.   

Abstract

INTRODUCTION AND AIMS: As inflammatory bowel diseases [IBD] affect female patients almost exclusively during their reproductive age, issues related to fertility, fecundity, pregnancy, delivery, and lactation are of utmost importance. Lack of education and misconceptions regarding the effect of disease and/or treatment on reproductive outcome may lead to voluntary childlessness and/or development of unwanted cervical pathologies which may impact tremendously on patients' welfare and quality of life. The aims of this study were to assess the perspectives of IBD patients on fertility, pregnancy and its outcomes, and lactation, as well as their awareness of human papillomavirus [HPV]-related pathologies and screening for cervical cancer.
METHODS: This prospective study was performed across nine different Mediterranean IBD centres between 2014 and 2015 and included consecutive female IBD patients between the ages of 16 and 50 years. All patients responded to a questionnaire based on ECCO guidelines.
RESULTS: A total of 348 IBD female patients with a mean age of 37.4 (standard deviation [SD] ± 2.1) years were recruited; 50% had a diagnosis of ulcerative colitis, 49.4% had Crohn`s disease, and 0.6% patients had a diagnosis of indeterminate colitis [IC]. A significant proportion of patients [ > 60%] were afraid that IBD may lead to a complicated pregnancy and that the disease itself and/or its medications can cause fetal harm. Patients had similar concerns that IBD can be transmitted to their offspring as well as with regard to breastfeeding. Counselling from health care professionals with regard to fertility, pregnancy, and lactation was associated positively with the highest number of pregnancies and inversely with the lowest number of patients who considered voluntary childlessness [p < 0.0001]. Patients with a higher level of education were more likely to get pregnant [p = 0.004]. There was a low uptake of the HPV vaccine. However, there was a reasonably good uptake of cervical cancer screening.
CONCLUSION: Our study demonstrates that women with IBD have misperceptions about fertility, pregnancy, and health maintenance. We also show that education by physicians has a positive influence. We thus conclude that improved multidisciplinary approaches should be used to educate and implement European guidelines for women with IBD.
Copyright © 2016 European Crohn’s and Colitis Organisation (ECCO). Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Inflammatory bowel disease; cervical screening; fertility; medications; pregnancy

Mesh:

Year:  2016        PMID: 26783343     DOI: 10.1093/ecco-jcc/jjw011

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  13 in total

1.  Antenatal Management for Women with Inflammatory Bowel Disease: Experience from Our 'IBD MOM' Clinic.

Authors:  Ariella Bar-Gil Shitrit; Yael Cohen; Ori Hassin; Ami Ben Ya'acov; Rivkah Farkash; Benjamin Koslowsky; Yael Milgrom; Dan Meir Livovsky; Arnon Samueloff; Eran Goldin; Sorina Grisaru-Granovsky
Journal:  Dig Dis Sci       Date:  2018-04-06       Impact factor: 3.199

2.  Multidisciplinary Team-Based Approaches to IBD Management: How Might "One-Stop Shopping" Work for Complex IBD Care?

Authors:  Chang Kyun Lee; Gil Y Melmed
Journal:  Am J Gastroenterol       Date:  2017-05-16       Impact factor: 10.864

3.  Ovarian Reserve Assessed by the Anti-Mullerian Hormone and Reproductive Health Parameters in Women With Crohn´s Disease, a Case-Control Study.

Authors:  T Koller; J Kollerová; T Hlavatý; B Kadlečková; J Payer
Journal:  Physiol Res       Date:  2021-11-30       Impact factor: 1.881

Review 4.  Impact of inflammatory bowel disease activity and thiopurine therapy on birth weight: A meta-analysis.

Authors:  Begoña Gonzalez-Suarez; Shreyashee Sengupta; Alan C Moss
Journal:  World J Gastroenterol       Date:  2017-12-07       Impact factor: 5.742

5.  Patients' perceptions of the impact of ulcerative colitis on social and professional life: results from the UC-LIFE survey of outpatient clinics in Spain.

Authors:  Xavier Calvet; Federico Argüelles-Arias; Antonio López-Sanromán; Luis Cea-Calvo; Berta Juliá; Cristina Romero de Santos; Daniel Carpio
Journal:  Patient Prefer Adherence       Date:  2018-09-18       Impact factor: 2.711

Review 6.  Insights into the treatment of inflammatory bowel disease in pregnancy.

Authors:  Sarah E Shannahan; Jonathan M Erlich; Mark A Peppercorn
Journal:  Therap Adv Gastroenterol       Date:  2019-05-27       Impact factor: 4.409

7.  Systematic review: the consequences of psychosocial effects of inflammatory bowel disease on patients' reproductive health.

Authors:  Satvinder Purewal; Sarah Chapman; Wladyslawa Czuber-Dochan; Christian Selinger; Helen Steed; Matthew J Brookes
Journal:  Aliment Pharmacol Ther       Date:  2018-11-08       Impact factor: 8.171

8.  Pregnancy-Related Beliefs and Concerns of Inflammatory Bowel Disease Patients Modified After Accessing e-Health Portal.

Authors:  Reed T Sutton; Kelsey Wierstra; Jasmin Bal; Kathleen P Ismond; Levinus A Dieleman; Brendan P Halloran; Karen I Kroeker; Richard N Fedorak; Keri-Ann Berga; Vivian W Huang
Journal:  J Can Assoc Gastroenterol       Date:  2019-12-19

Review 9.  Sexual Dysfunction in Inflammatory Bowel Disease: What the Specialist Should Know and Ask.

Authors:  Edith Perez de Arce; Rodrigo Quera; Jaqueline Ribeiro Barros; Ligia Yukie Sassaki
Journal:  Int J Gen Med       Date:  2021-05-24

Review 10.  Familial and ethnic risk in inflammatory bowel disease.

Authors:  Maria Pia Costa Santos; Catarina Gomes; Joana Torres
Journal:  Ann Gastroenterol       Date:  2017-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.